#dnaseq | Explore Tumblr posts and blogs

biodiscovery-group · 4 years ago

Photo

CERTIFICATE WORKSHOP in NEXT GENERATION SEQUENCING | Live session | Only in ₹ 250 & US $ 5 🤳🤳 Video of the session will be recorded and shared with the registered participants. Register from here https://www.townscript.com/e/ngs-course Check out https://www.bdglifesciences.com/ for other programs like Courses, Workshops & Research Projects #envisionwithbdg #itsdifferentbybiodiscovery #bdglifesciences #bioinformatics #biotechnology #bioinformaticscompany #10yearsofexcellence #biodiscoverygroup #onlineteaching #onlinelearning #NGSDataAnalysis #nextgenerationsequencing #functionalgenomics #genomeanalysis #rna #rnaseq #WholeGenome #DNAseq https://www.instagram.com/p/CLmgMUujaAX/?igshid=dgejnjn9hdxz

#envisionwithbdg #itsdifferentbybiodiscovery #bdglifesciences #bioinformatics #biotechnology #bioinformaticscompany #10yearsofexcellence #biodiscoverygroup #onlineteaching #onlinelearning #ngsdataanalysis #nextgenerationsequencing #functionalgenomics #genomeanalysis #rna #rnaseq #wholegenome #dnaseq

0 notes

evoldir · 3 years ago

Text

Fwd: Postdoc:UCDAVIS.HighlandAdaptationPopgenExpression

Begin forwarded message: > From: [email protected] > Subject: Postdoc:UCDAVIS.HighlandAdaptationPopgenExpression > Date: 23 March 2016 at 06:33:42 GMT > To: [email protected] > > > --001a113e012af347f2052eaabb10 > Content-Type: text/plain; charset=UTF-8 > Content-Transfer-Encoding: quoted-printable > > *Postdoctoral Positions on Highland Adaptation in Maize at UC Davis* > > > *Two postdoc positions are available in the labs of Jeffrey Ross-Ibarra and > Daniel Runcie at UC Davis* to study the functional and evolutionary > genetics of maize adaptation to highland environments. This is a joint > project with labs at Iowa State, USDA-ARS, and Langebio, Mexico. We will > draw on population genetics, quantitative genetics, and functional genomics > approaches to identify the genetic basis and evolutionary history of > highland phenotypes. > > > The position in Dr. Runcie’s lab will be responsible for generating and > analyzing RNAseq data on highland and lowland genotypes in the lab and in > the field. We are starting two parallel projects. The first will > characterize gene expression evolution at a population level, using a > diverse sample of landraces from high and low elevation locations. The > second will use gene expression to validate and functionally interrogate a > strong candidate region for several highland phenotypes. Preference will be > given to candidates with experience preparing RNAseq or DNAseq libraries, > field tissue collection, and proficiency in unix, R, and other > bioinformatics tools. A strong background in evolutionary biology is also > desired. > > > The position in Dr. Ross-Ibarra’s lab will be responsible primarily > responsible for population genetic analysis of introgression and adaptation > using genotyping and sequence data from replicate populations of wild and > domesticated maize in the highlands of Central Mexico. The ideal > candidate will have experience in population genetics, proficiency in > bioinformatics, and a strong background in evolutionary biology. > > > Opportunities exist for both positions to additionally collaborate on a > number of ongoing projects in both labs, including statistical methods for > gene expression analysis, quantitative genetic and functional genomic > analysis of adaptive phenotypes, and population genetics of reinforcement > or genetic load. Both positions are for one year, with the potential for a > second year of support conditional on performance. Start dates are > open-ended, with preference for earlier dates. > > > UC Davis has extremely strong programs in both plant and evolutionary > biology. Candidates would have the opportunity to interact with members of > the Center for Population Biology and the Genome Center as well as the > Dept. of Plant Sciences. Additional information about our labs please > visit runcielab.ucdavis.edu or rilab.org. > > > For more information or to apply, please send a cover letter and a CV with > a list of references to [email protected] for the first position, or to > [email protected] for the second. > > > UC Davis provides equal opportunity to all qualified individuals and does > not discriminate on the basis of race, color, creed, age, marital status, > sex, gender, religion, sexual orientation, gender identity or expression, > national origin, veteran status or disability. UC Davis provides reasonable > accommodations to applicants with disabilities; if you need such > accommodation for any part of the application process, please contact the > office of Graduate Studies at [email protected]. > ____________ > > Jeffrey Ross-Ibarra > > Dept. of Plant Sciences > 262 Robbins Hall, Mail Stop 4 > University of California > One Shields Ave > Davis, CA 95616 > > Tel: 530-752-1152 > @jrossibarra > www.rilab.org > > --001a113e012af347f2052eaabb10 > Content-Type: text/html; charset=UTF-8 > Content-Transfer-Encoding: quoted-printable > >

Postdoctoral Positions on Highland Adaptation in Maize at UC Davis

>

Two postdoc positions are available in the labs of Jeffrey Ross-Ibarra and Daniel Runcie at UC Davis to study the functional and evolutionary genetics of maize adaptation to highland environments. This is a joint project with labs at Iowa State, USDA-ARS, and Langebio, Mexico. We will draw on population genetics, quantitative genetics, and functional genomics approaches to identify the genetic basis and evolutionary history of highland phenotypes.

>

The position in Dr. Runcie’s lab will be responsible for generating and analyzing RNAseq data on highland and lowland genotypes in the lab and in the field. We are starting two parallel projects. The first will characterize gene expression evolution at a population level, using a diverse sample of landraces from high and low elevation locations. The second will use gene expression to validate and functionally interrogate a strong candidate region for several highland phenotypes. Preference will be given to candidates with experience preparing RNAseq or DNAseq libraries, field tissue collection, and proficiency in unix, R, and other bioinformatics tools. A strong background in evolutionary biology is also desired.

>

The position in Dr. Ross-Ibarra’s lab will be responsible primarily responsible for population genetic analysis of introgression and adaptation using genotyping and sequence data from replicate populations of wild and domesticated maize in the highlands of Central Mexico. The ideal candidate will have experience in population genetics, proficiency in bioinformatics, and a strong background in evolutionary biology.

>

Opportunities exist for both positions to additionally collaborate on a number of ongoing projects in both labs, including statistical methods for gene expression analysis, quantitative genetic and functional genomic analysis of adaptive phenotypes, and population genetics of reinforcement or genetic load. Both positions are for one year, with the potential for a second year of support conditional on performance. Start dates are open-ended, with preference for earlier dates.

>

UC Davis has extremely strong programs in both plant and evolutionary biology. Candidates would have the opportunity to interact with members of the Center for Population Biology and the Genome Center as well as the Dept. of Plant Sciences. Additional information about our labs please visit runcielab.ucdavis.edu or rilab.org.

>

For more information or to apply, please send a cover letter and a CV with a list of references to [email protected] for the first position, or to [email protected] for the second.

>

UC Davis provides equal opportunity to all qualified individuals and does not discriminate on the basis of race, color, creed, age, marital status, sex, gender, religion, sexual orientation, gender identity or expression, national origin, veteran status or disability. UC Davis provides reasonable accommodations to applicants with disabilities; if you need such accommodation for any part of the application process, please contact the office of Graduate Studies at [email protected].

____________ Jeffrey Ross-Ibarra Dept. of Plant Sciences 262 Robbins Hall, Mail Stop 4 University of California One Shields Ave Davis, CA 95616 Tel: 530-752-1152 @jrossibarra www.rilab.org

>

> > --001a113e012af347f2052eaabb10-- > via IFTTT

0 notes

dr-afsaeed · 4 years ago

Text

16 Postdoc Positions, Masaryk University, Czech Republic

16 Postdoc Positions, Masaryk University, Czech Republic (1) Postdoctoral Position: Summary Of Postdoc Position: The successful candidate will lead the analysis of data from multiomics profiles spanning from targeted (16S rRNA seq) and whole-metagenomic profiles, transcriptomic profiles (RNAseq, miRNA seq), tumour cancer panel profiles (DNAseq) and metabolomic profiles in association with…

View On WordPress

0 notes

martynnx-blog · 6 years ago

Text

Precision Medicine Diagnostics Market Research Report 2018 - Detailed Analysis of Future Trends & Growth Opportunities

Precision medicine aims to alter the treatments based on individual characteristics, including differences in genetics, environment, and lifestyle. It has the potential to transform the delivery of care for a variety of diseases. Precision medicine implicate the application of panomic analysis and systems biology to inspect the cause of an individual patient’s diseased condition at the molecular level and then to apply targeted treatments to address that individual patient’s disease. Precision medicine aims to make medication and medical practices efficient and cost effective. By using the precision medicine, doctors recognize genetic makeup of the subject, which helps doctors to prescribe the right drug with appropriate dose.

Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/2422

Precision Medicine Diagnostics Market- Drivers

Precision medicine diagnostics market is expected to expand at rapid pace in near future, owing to increasing number of pipeline studies to develop new treatment for cancer. For instance, in January 2016, University of Arkansas initiated the clinical trial for fresh tissue biopsy to study the further advancements in bio-specimens (blood cellular free component, e.g., plasma, serum, tissue, urine), in order to develop precision medicine for lung cancer management and screening (synergy with imaging). Fresh tissue biopsy involves taking a small sample of tissue from the body part for further microscopic examination. The study is estimated to complete in December 2019.

Moreover, government initiatives to create awareness among the community health worker is expected to boost growth of the precision medicine diagnostics market. For instance, in March 2018, the Division of Community Engagement and University of Agricultural and Horticultural Sciences (UAHS) Center for Applied Genetics and Genomic Medicine partnered with the University Of Arizona Banner Health Research Program to develop and implement a unique and culturally conscious approach to increase precision medicine literacy, particularly among underserved and marginalized populations. The program has been named as ‘Precision Medicine Community Health Workers/Promoters for All of Us’.

Furthermore, in October 2017, the National Institutes of Health (NIH) collaborated with 11 biopharmaceutical companies to launch a five-year Accelerating Cancer Therapies (PACT) program, this collaboration is focused on enhancing precision medicine approaches to cancer care. Initial focus of PACT is to identify, develop, and validate robust biomarkers (standardized biological markers) of disease and treatment response, to advance new immunotherapy treatments that controls immune system to attack cancer. The total cost of the project was US$ 215 million.

Precision Medicine Diagnostics Market- Restraints

However, barriers in management of big data (large database including individual’s genetics, environment, and lifestyle to ensure delivery of appropriate therapies) in Electronic health records (EHR) may hamper growth of the precision medicine diagnostics market. Big data refers to the large or complex data. EHR maintains the electronic record of patient health information generated by one or more healthcare service provider. For Instance, in March 2018, Health It Analytics stated that there was rise in adoption of precision medicine by healthcare organizations, but insufficient data management was major challenge that results into turning organizations to Artificial Intelligence (AI) and machine learning techniques to manage large amount of data.

Precision Medicine Diagnostics Market- Regional Analysis

On the basis of region, the global precision medicine diagnostics market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Geographically, North America accounts for the largest share in the global precision medicine diagnostics market, owing to increasing awareness and initiative related to precision medicine in the North America. For instance, in 2015, the U.S Government launched the Precision Medicine Initiative to revolutionize method to improve health and treat disease. The precision medicine initiative will enable health care providers to adapt new treatment and prevention strategies to people’s unique characteristics, including their genome sequence, micro-biome composition, health history, lifestyle, and diet.

Europe is anticipated to witness significant growth in the precision medicine diagnostics market over the forecast period due to expansion of key players in the region. For instance, in February 2018, QIAGEN N.V. collaborated with and Sentieon, Inc., to advance precision medicine by delivering Sentieon’s highly efficient variant-calling software. Qiagen N.V. is expected to incorporate Sentieon’s variant-calling software into its bioinformatics portfolio, supporting thousands of next-generation sequencing (NGS) labs and also planned to offer its customer with Sentieon DNAseq and Sentieon TNseq products for germline and somatic variant calling.

Some of the major players operating in the precision medicine diagnostics market include Intomics, Ferrer Incode, Nanostring Technologies, Inc., Tepnel Pharma Services, Pfizer, Inc., Novartis AG, Teva Pharmaceuticals, Merck & Co., Inc., Qiagen N.V., and Quest Diagnostics.

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/2422

Precision Medicine Diagnostics Market- Taxonomy

By Technology:

Bioinformatics ,Gene Sequencing ,Drug Discovery ,Precision Molecular Diagnostics ,Big Data Analytics

By Application:

Oncology ,Breast cancers ,Lung Cancer ,Others ,CNS ,Hematology ,Respiratory ,Immunology ,Others

#Precision Medicine Diagnostics Market #Precision Medicine Diagnostics Market 2018 #Precision Medicine Diagnostics

0 notes

larryhbernsteinme · 7 years ago

Text

QIAGEN - International Leader in NGS and RNA Sequencing

QIAGEN – International Leader in NGS and RNA Sequencing

Reporter: Aviva Lev-Ari, PhD, RN

The reader is encouraged to review all the products of QIAGEN on the company web site.

miRCURY Exosome Kits

For enrichment of exosomes and other extracellular vesicles from serum/plasma or cell/urine/CSF samples

Excellent recovery of exosomes and other extracellular vesicles

Easy and…

View On WordPress

#DNASeq Data Analysis #Molecular Diagnostics #RNASeq Data Analysis

0 notes

biostatevents · 8 years ago

Text

Seminar: 01 February 2017, 3pm: Jun Ye on "Enable Precision Data for Precision Medicine"

Wednesday, 01 February 2017, 3pm followed by social hour Room 2700, Mission Hall: Global Health and Clinical Sciences Building 550 16th Street, San Francisco, CA

Jun Ye, PhD CEO Sentieon

Enable Precision Data for Precision Medicine

Sentieon (www.sentieon.com), incorporated in 2014, develops and supplies a suite of bioinformatics secondary analysis tools that process genomics data with high computing efficiency, fast turnaround time, exceptional accuracy, and 100% consistency. Current released products include Sentieon DNAseq, a germline DNA pipeline, and Sentieon TNseq, for tumor-normal somatic variant detection. The Sentieon tools are easily scalable, easily deployable, easily upgradable, software-only solutions. The Sentieon tools achieve their efficiency and consistency through optimized computing algorithm design and enterprise-strength software implementation, and achieve high accuracy using the industry’s most validated mathematics models. Sentieon products have won multiple awards at precisionFDA challenges, and ranked first place on the most recent ICGC-TCGA DREAM Mutation Calling challenge leaderboard in all three categories (snv, indel, SV). We strive to enable precision genomics data for precision medicine.

0 notes

biodiscovery-group · 4 years ago

Photo

NGS SUMMER SCHOOL | 15 DAYS | A COMPLETE PROGRAM ON NGS DATA ANALYSIS 1- RNASeq-reference based 2- WGS-DNASeq- Variants & Mapping 3- MetaGenomics- OTUs 4- MetaGenomics- AntiBiotic Resistance 5- MetaTranscriptomics- Taxonomy Function https://www.bdglifesciences.com/ #NextGenerationSequencingDataAnalysis #biotechnology #biotech #biotechindia #bioinfo #bioinfoindia #wholegenomesequencing #wgs #itsdifferentbybiodiscovery #bdglifesciences #genomics #computational_genomics #genetics #dna_sequencing #onlinebioinformaticstraining #metagenomics #metatranscriptomics #rnaseq #dnaseq #computationalgenomics https://www.instagram.com/p/CDilGEXDAw0/?igshid=mye9ikv18hjf

0 notes